Yu Mi

1.9k total citations
31 papers, 1.5k citations indexed

About

Yu Mi is a scholar working on Biomaterials, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Yu Mi has authored 31 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Biomaterials, 13 papers in Molecular Biology and 12 papers in Biomedical Engineering. Recurrent topics in Yu Mi's work include Nanoparticle-Based Drug Delivery (16 papers), Nanoplatforms for cancer theranostics (9 papers) and RNA Interference and Gene Delivery (6 papers). Yu Mi is often cited by papers focused on Nanoparticle-Based Drug Delivery (16 papers), Nanoplatforms for cancer theranostics (9 papers) and RNA Interference and Gene Delivery (6 papers). Yu Mi collaborates with scholars based in United States, China and Singapore. Yu Mi's co-authors include Si‐Shen Feng, Jing Zhao, Andrew Z. Wang, Yutao Liu, Benjamin G. Vincent, C. Tilden Hagan, Kyle C. Roche, Feifei Yang, Yanfei Qi and Jing Zhao and has published in prestigious journals such as Advanced Materials, Biomaterials and Cancer Research.

In The Last Decade

Yu Mi

31 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Mi United States 18 834 760 502 303 243 31 1.5k
Hanqing Qian China 25 752 0.9× 725 1.0× 689 1.4× 254 0.8× 220 0.9× 58 1.8k
Edgar Pérez‐Herrero Spain 16 771 0.9× 760 1.0× 707 1.4× 252 0.8× 130 0.5× 21 1.9k
Anna Scomparin Israel 24 595 0.7× 607 0.8× 834 1.7× 290 1.0× 299 1.2× 47 1.8k
Zhiting Cao China 21 823 1.0× 887 1.2× 1.1k 2.2× 290 1.0× 236 1.0× 27 2.1k
Jianqin Wan China 20 649 0.8× 712 0.9× 550 1.1× 164 0.5× 164 0.7× 32 1.4k
Dawei Zhang China 22 742 0.9× 923 1.2× 570 1.1× 171 0.6× 146 0.6× 34 1.6k
Sang Mun Bae South Korea 18 858 1.0× 622 0.8× 742 1.5× 168 0.6× 132 0.5× 26 1.8k
Qingsong Yu China 22 787 0.9× 933 1.2× 583 1.2× 153 0.5× 126 0.5× 57 1.7k
Mami Murakami Canada 7 904 1.1× 713 0.9× 490 1.0× 191 0.6× 88 0.4× 8 1.4k
Jilong Wang China 21 543 0.7× 557 0.7× 615 1.2× 192 0.6× 232 1.0× 46 1.5k

Countries citing papers authored by Yu Mi

Since Specialization
Citations

This map shows the geographic impact of Yu Mi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Mi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Mi more than expected).

Fields of papers citing papers by Yu Mi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Mi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Mi. The network helps show where Yu Mi may publish in the future.

Co-authorship network of co-authors of Yu Mi

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Mi. A scholar is included among the top collaborators of Yu Mi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Mi. Yu Mi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Zhijian, et al.. (2025). Ginsenosides as Functional Foods: A Novel Approach for Regulating Gut Microbiota. ACS Food Science & Technology. 5(4). 1255–1257. 1 indexed citations
2.
Zhang, Zhiqiang, et al.. (2025). The Microbiota–Gut–Brain Axis in Autism: Associations, Causal Inference, and Interventions—A Narrative Review. Pathogens. 14(11). 1145–1145. 1 indexed citations
3.
Hagan, C. Tilden, Xi Tian, Feifei Yang, et al.. (2021). Co-delivery of etoposide and cisplatin in dual-drug loaded nanoparticles synergistically improves chemoradiotherapy in non-small cell lung cancer models. Acta Biomaterialia. 124. 327–335. 54 indexed citations
4.
Hagan, C. Tilden, et al.. (2020). Enhancing Combined Immunotherapy and Radiotherapy through Nanomedicine. Bioconjugate Chemistry. 31(12). 2668–2678. 16 indexed citations
5.
Yang, Feifei, Yusra B. Medik, Liantao Li, et al.. (2020). Nanoparticle Drug Delivery Can Reduce the Hepatotoxicity of Therapeutic Cargo. Small. 16(7). e1906360–e1906360. 21 indexed citations
6.
Mi, Yu, Feifei Yang, Cameron J. Bloomquist, et al.. (2019). Nanomedicine: Biologically Targeted Photo‐Crosslinkable Nanopatch to Prevent Postsurgical Peritoneal Adhesion (Adv. Sci. 19/2019). Advanced Science. 6(19). 1 indexed citations
7.
Hagan, C. Tilden, Xi Tian, Feifei Yang, et al.. (2018). Nanoparticle co-delivery of wortmannin and cisplatin synergistically enhances chemoradiotherapy and reverses platinum resistance in ovarian cancer models. Biomaterials. 169. 1–10. 70 indexed citations
8.
Mi, Yu, Christof C. Smith, Feifei Yang, et al.. (2018). A Dual Immunotherapy Nanoparticle Improves T‐Cell Activation and Cancer Immunotherapy. Advanced Materials. 30(25). e1706098–e1706098. 175 indexed citations
9.
Mi, Yu, Joy Wolfram, Chaofeng Mu, et al.. (2016). Enzyme-responsive multistage vector for drug delivery to tumor tissue. Pharmacological Research. 113(Pt A). 92–99. 50 indexed citations
10.
Scott, Bronwyn, Jianliang Shen, Sara Nizzero, et al.. (2016). A pyruvate decarboxylase-mediated therapeutic strategy for mimicking yeast metabolism in cancer cells. Pharmacological Research. 111. 413–421. 8 indexed citations
11.
Tian, Jing, Zachary L. Rodgers, Xiaomeng Wan, et al.. (2016). Nanoparticle delivery of chemotherapy combination regimen improves the therapeutic efficacy in mouse models of lung cancer. Nanomedicine Nanotechnology Biology and Medicine. 13(3). 1301–1307. 23 indexed citations
12.
Mi, Yu, et al.. (2016). Application of nanotechnology to cancer radiotherapy. Cancer Nanotechnology. 7(1). 11–11. 120 indexed citations
13.
Fan, Daidi, et al.. (2014). Study of human-like collagen adsorption on true bone ceramic. Journal of chemical and pharmaceutical research. 6(1). 1 indexed citations
14.
Mi, Yu, Jing Zhao, & Si‐Shen Feng. (2013). Multimodality treatment of cancer by co-encapsulation of docetaxel and iron oxides in heceptin-conjugated nanoparticles of a blend of biodegradable copolymers. Journal of Controlled Release. 172(1). e91–e91. 1 indexed citations
15.
Zhao, Jing, Yu Mi, & Si‐Shen Feng. (2013). Targeted co-delivery of docetaxel and siPlk1 by herceptin-conjugated vitamin E TPGS based immunomicelles. Biomaterials. 34(13). 3411–3421. 80 indexed citations
16.
Mi, Yu, Xiaoli Liu, Jing Zhao, Jun Ding, & Si‐Shen Feng. (2012). Multimodality treatment of cancer with herceptin conjugated, thermomagnetic iron oxides and docetaxel loaded nanoparticles of biodegradable polymers. Biomaterials. 33(30). 7519–7529. 106 indexed citations
17.
Mi, Yu, Jing Zhao, & Si‐Shen Feng. (2012). Vitamin E TPGS prodrug micelles for hydrophilic drug delivery with neuroprotective effects. International Journal of Pharmaceutics. 438(1-2). 98–106. 75 indexed citations
18.
19.
20.
Liu, Yutao, Yu Mi, Jing Zhao, & Si‐Shen Feng. (2011). Multifunctional silica nanoparticles for targeted delivery of hydrophobic imaging and therapeutic agents. International Journal of Pharmaceutics. 421(2). 370–378. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hanqing Qian Breakdown of academic impact, for papers by Edgar Pérez‐Herrero Breakdown of academic impact, for papers by Anna Scomparin Breakdown of academic impact, for papers by Zhiting Cao Breakdown of academic impact, for papers by Jianqin Wan Breakdown of academic impact, for papers by Dawei Zhang Breakdown of academic impact, for papers by Sang Mun Bae Breakdown of academic impact, for papers by Qingsong Yu Breakdown of academic impact, for papers by Mami Murakami Breakdown of academic impact, for papers by Jilong Wang
Rankless by CCL
2026